www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for September, 2009

The Orthopaedic Trauma Institute at San Francisco General Hospital and the University of California, San Francisco has been selected to be one of 12 core clinical centers in a newly established Extremity Trauma Clinical Research Consortium.

Lees meer..

  • 0 Comments
  • Filed under: 3
  • The patient is still in the operating room, and the prognosis is not good.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Duke-National University of Singapore Graduate Medical School opened its new campus in Singapore, giving the fledgling school a permanent base of operations.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Celsion stock sale to raise $7.1M

    Money-losing Celsion Corp. has more money on the way, arranging an institutional stock sale that should raise about $7 million. (CLSN)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • International health-technology giant Covidien plc has agreed to buy brain-monitoring device company Aspect Medical Systems Inc. for about $210 million, the two companies reported Monday. (COV)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Kristen Diane Parker — the former surgical technician at Denver’s Rose Medical Center linked to a wave of hepatitis C infections among patients — has been sentenced to 20 years in federal prison under a plea agreement.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Abbott Laboratories expects to close early next year on a more than $7 billion deal to buy the pharmaceutical business of Belgian conglomerate Solvay Group. (ABT)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Allied Healthcare posts loss

    Allied Healthcare Products Inc. posted a loss and saw its sales drop in the fourth quarter and full year 2009 due to recession-driven budget cuts in health care.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Novartis has received a positive opinion recommending European Union (EU) approval of QAB149 (indacaterol) for maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease (COPD).
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • A report published by the Center for Healthcare Supply Chain Research, the research foundation of the Healthcare Distribution Management Association (HDMA), indicates that in 2008, that $253 billion in prescription drug sales were completed through primary healthcare distributors, representing nearly 85% of the entire market.
    Lees meer..

  • 0 Comments
  • Filed under: Pharmaceuten